EurekAlert! Experimental Biology 2022 - Newsroom

Newsroom

Latest News from Our Host Societies

Updates every hour. Last Updated: 19-Oct-2026 13:17 ET (19-Oct-2026 17:17 GMT/UTC)

Study reveals the science behind those irresistible puppy-dog eyes

Experimental Biology
Peer-Reviewed Publication

Can’t resist your pup’s adoring expression when he begs for a treat? A new study reveals key anatomical features that could explain what makes dogs’ faces so appealing. The findings also suggest that humans contributed to dogs’ ability to form facial expressions through thousands of years of selective breeding.

Meeting: Experimental Biology 2022

Researchers uncover how sugar substitutes disrupt liver detoxification

Experimental Biology
Peer-Reviewed Publication

Results from a new study suggest that two sugar substitutes disrupt the function of a protein that plays a vital role in liver detoxification and the metabolism of certain drugs. These sugar substitutes, also known as non-nutritive sweeteners, provide a sweet taste with few or no calories.

Meeting: Experimental Biology 2022

Study reveals how deadly tick disease spreads

Experimental Biology
Peer-Reviewed Publication

Findings from a new study are providing important insights into the spread of Rocky Mountain spotted fever, which is transmitted from dogs to people through ticks. The new data are being used to create models that could help predict, and possibly prevent, future outbreaks.

Meeting: Experimental Biology 2022

Vitamin K shows evidence of brain benefits in rats

Experimental Biology
Peer-Reviewed Publication

In a new study conducted in rats, scientists report evidence that vitamin K could help protect against aging-related cognitive declines associated with Alzheimer’s disease and other forms of dementia.

Meeting: Experimental Biology 2022

Diagnosing sports-related concussions may be harder than previously thought

Experimental Biology
Peer-Reviewed Publication

In a new study, many athletes reported symptoms that are often used to diagnose concussions even though they did not suffer a head injury. The findings suggest that some symptoms, such as fatigue and neck pain, could be attributed to intense exercise rather than a brain injury.

Meeting: Experimental Biology 2022

Gut bacteria may contribute to blood pressure medicine resistance

Experimental Biology
Peer-Reviewed Publication

Almost half of the U.S. adult population has high blood pressure — or hypertension — and about 20% of these patients have treatment-resistant hypertension. The reason why some people are resistant to treatment has been a mystery, but new study results show that a certain gut bacterium may be an important factor.

Meeting: Experimental Biology 2022

Autism-associated brain differences can be observed in the womb

Experimental Biology
Peer-Reviewed Publication

A new study using prenatal brain scans revealed significant differences in brain structures at around 25 weeks’ gestation between children who were later diagnosed with ASD and those who were not. The study adds to mounting evidence that autism begins in early development and suggests possible opportunities to identify the disorder at an earlier age.

Meeting: Experimental Biology 2022

Proteins in saliva could aid in COVID-19 detection and predict severe illness

Experimental Biology
Peer-Reviewed Publication

Researchers have identified a family of proteins that is significantly elevated in the saliva of patients hospitalized with COVID-19. The proteins, known as ephrin ligands, could potentially serve as a biomarker to help doctors identify patients who are at risk for serious illness.

Meeting: Experimental Biology 2022

Scientists identify cancer biomarkers in breast milk

Experimental Biology
Peer-Reviewed Publication

A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers that researchers identified using breast milk.

Meeting: Experimental Biology 2022

Vitamin C could help reduce toxic side effects of common cancer treatment

Experimental Biology
Peer-Reviewed Publication

A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin. Although clinical studies would be needed to determine the safety and effectiveness of taking vitamin C during doxorubicin treatment, the findings suggest vitamin C may represent a promising opportunity to reduce some of the drug’s most debilitating side effects.

Meeting: Experimental Biology 2022

1
2
3